‘What Safeguards Are Going To Be Needed?’: Marc Veasey Asks Expert About FDA Clinical Requirements

During a House Energy Committee hearing before the Congressional recess, Rep. Marc Veasey (D-TX) asked Dr. Aaron J Kowalski PhD, CEO of Breakthrough T1D about proposed FDA clinical requirements.

Stay Connected
Forbes Breaking News on X: https://x.com/ForbesTVNews
Forbes Breaking News on TikTok: https://www.tiktok.com/@forbestvnews
More From Forbes: http://forbes.com